{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T04:26:47Z","timestamp":1785904007926,"version":"3.56.0"},"reference-count":118,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,1,11]],"date-time":"2021-01-11T00:00:00Z","timestamp":1610323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,1,11]],"date-time":"2021-01-11T00:00:00Z","timestamp":1610323200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P50CA062924"],"award-info":[{"award-number":["P50CA062924"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Familial Cancer"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1007\/s10689-020-00226-w","type":"journal-article","created":{"date-parts":[[2021,1,11]],"date-time":"2021-01-11T03:04:12Z","timestamp":1610334252000},"page":"57-67","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Comparison of universal screening in major lynch-associated tumors: a systematic review of literature"],"prefix":"10.1007","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0595-5434","authenticated-orcid":false,"given":"George","family":"Kunnackal John","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vipin","family":"Das Villgran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Caufield-Noll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francis M.","family":"Giardiello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,11]]},"reference":[{"key":"226_CR1","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1038\/ajg.2014.186","volume":"109","author":"FM Giardiello","year":"2014","unstructured":"Giardiello FM, Allen JI, Axilbund JE et al (2014) Guidelines on genetic evaluation and management of Lynch syndrome: a consensus statement by the US Multi-society Task Force on colorectal cancer. Am J Gastroenterol 109:1159\u20131179","journal-title":"Am J Gastroenterol"},{"key":"226_CR2","first-page":"455","volume":"19","author":"HT Lynch","year":"2005","unstructured":"Lynch HT, Lynch JF (2005) What the physician needs to know about Lynch syndrome: an update. Oncology (Williston Park) 19:455\u2013463","journal-title":"Oncology (Williston Park)"},{"key":"226_CR3","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1038\/ajg.2017.212","volume":"112","author":"P Kanth","year":"2017","unstructured":"Kanth P, Grimmett J, Champine M et al (2017) Hereditary colorectal polyposis and cancer syndromes: a primer on diagnosis and management. Am J Gastroenterol 112:1509\u20131525","journal-title":"Am J Gastroenterol"},{"key":"226_CR4","first-page":"628","volume":"23","author":"M Koeneman","year":"2013","unstructured":"Koeneman M, Kruse AJ, Gubbels CS et al (2013) Routine use of a screening questionnaire improves detection of individuals at possible risk of hereditary gynecologic cancer. Int J Gynecol Cancer 23:628","journal-title":"Int J Gynecol Cancer"},{"key":"226_CR5","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s10689-017-9973-1","volume":"16","author":"MR Akbari","year":"2017","unstructured":"Akbari MR, Zhang S, Cragun D et al (2017) Correlation between germline mutations in MMR genes and microsatellite instability in ovarian cancer specimens. Fam Cancer 16:351\u2013355","journal-title":"Fam Cancer"},{"key":"226_CR6","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1464-410X.2005.05585.x","volume":"96","author":"M Roupret","year":"2005","unstructured":"Roupret M, Coulet F, Azzouzi A-R et al (2005) Accuracy of the routine detection of mutation in mismatch repair genes in patients with susceptibility to hereditary upper urinary tract transitional cell carcinoma. BJU Int 96:149\u2013151","journal-title":"BJU Int"},{"key":"226_CR7","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1001\/archinte.1981.00340050059016","volume":"141","author":"HT Lynch","year":"1981","unstructured":"Lynch HT, Lynch PM, Pester J et al (1981) The cancer family syndrome. Rare cutaneous phenotypic linkage of Torre\u2019s syndrome. Arch Intern Med 141:607\u2013611","journal-title":"Arch Intern Med"},{"key":"226_CR8","first-page":"217","volume":"146","author":"LM Randall","year":"2017","unstructured":"Randall LM, Pothuri B, Swisher EM et al (2017) Multi-disciplinary summit on genetics services for women with gynecologic cancers: a Society of Gynecologic Oncology White Paper. GynecolOncol 146:217","journal-title":"GynecolOncol"},{"key":"226_CR9","doi-asserted-by":"publisher","DOI":"10.1007\/s10689-020-00206-0","author":"G Kunnackal John","year":"2020","unstructured":"Kunnackal John G, Das Villgran V, Caufield-Noll C et al (2020) Worldwide variation in lynch syndrome screening: case for universal screening in low colorectal cancer prevalence areas. Fam Cancer. https:\/\/doi.org\/10.1007\/s10689-020-00206-0","journal-title":"Fam Cancer"},{"key":"226_CR10","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s10689-015-9782-3","volume":"14","author":"AR Lamba","year":"2015","unstructured":"Lamba AR, Moore AY, Moore T et al (2015) Defective DNA mismatch repair activity is common in sebaceous neoplasms, and may be an ineffective approach to screen for Lynch syndrome. Fam Cancer 14:259\u2013264","journal-title":"Fam Cancer"},{"key":"226_CR11","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1097\/DAD.0b013e31825f7efe","volume":"35","author":"EF Plocharczyk","year":"2013","unstructured":"Plocharczyk EF, Frankel WL, Hampel H et al (2013) Mismatch repair protein deficiency is common in sebaceous neoplasms and suggests the importance of screening for Lynch syndrome. Am J Dermatopathol 35:191\u2013195","journal-title":"Am J Dermatopathol"},{"key":"226_CR12","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1002\/path.1851","volume":"207","author":"RL Ward","year":"2005","unstructured":"Ward RL, Turner J, Williams R et al (2005) Routine testing for mismatch repair deficiency in sporadic colorectal cancer is justified. J Pathol 207:377\u2013384","journal-title":"J Pathol"},{"key":"226_CR13","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1056\/NEJMoa043146","volume":"352","author":"H Hampel","year":"2005","unstructured":"Hampel H, Frankel WL, Martin E et al (2005) Screening for the Lynch syndrome (hereditary nonpolyposis colorectal cancer). N Engl J Med 352:1851\u20131860","journal-title":"N Engl J Med"},{"key":"226_CR14","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1159\/000096868","volume":"74","author":"C Lamberti","year":"2006","unstructured":"Lamberti C, Mangold E, Pagenstecher C et al (2006) Frequency of hereditary non-polyposis colorectal cancer among unselected patients with colorectal cancer in Germany. Digestion 74:58\u201367","journal-title":"Digestion"},{"key":"226_CR15","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1093\/annonc\/mdl959","volume":"17","author":"F Bishehsari","year":"2006","unstructured":"Bishehsari F, Mahdavinia M, Malekzadeh R et al (2006) Patterns of K-ras mutation in colorectal carcinomas from Iran and Italy (a GruppoOncologicodell\u2019ItaliaMeridionale study): influence of microsatellite instability status and country of origin. Ann Oncol 17:91\u201396","journal-title":"Ann Oncol"},{"key":"226_CR16","first-page":"533","volume":"26","author":"B Shpitz","year":"2006","unstructured":"Shpitz B, Millman M, Ziv Y et al (2006) Predominance of younger age, advanced stage, poorly-differentiated and mucinous histology in Israeli Arab patients with colorectal cancer. Anticancer Res 26:533\u2013537","journal-title":"Anticancer Res"},{"key":"226_CR17","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.amjsurg.2006.02.015","volume":"191","author":"EY Chang","year":"2006","unstructured":"Chang EY, Dorsey PB, Johnson N et al (2006) A prospective analysis of microsatellite instability as a molecular marker in colorectal cancer. Am J Surg 191:646\u2013651","journal-title":"Am J Surg"},{"key":"226_CR18","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.humpath.2006.02.009","volume":"37","author":"M Yearsley","year":"2006","unstructured":"Yearsley M, Hampel H, Lehman A et al (2006) Histologic features distinguish microsatellite-high from microsatellite-low and microsatellite-stable colorectal carcinomas, but do not differentiate germline mutations from methylation of the MLH1 promoter. Hum Pathol 37:831\u2013838","journal-title":"Hum Pathol"},{"key":"226_CR19","first-page":"1445","volume":"87","author":"H-Y Jin","year":"2007","unstructured":"Jin H-Y, Ding Y-J, Liu X-F et al (2007) Screening the hereditary nonpolyposis colorectal cancer by revised Bethesda guideline: a cohort study of 110 cases. Chung-Hua Hsueh TsaChih 87:1445\u20131447","journal-title":"Chung-Hua Hsueh TsaChih"},{"key":"226_CR20","first-page":"228","volume":"39","author":"LP Tan","year":"2007","unstructured":"Tan LP, Ng BK, Balraj P et al (2007) No difference in the occurrence of mismatch repair defects and APC and CTNNB1 genes mutation in a multi-racial colorectal carcinoma patient cohort. Pathology 39:228\u2013234","journal-title":"Pathology"},{"key":"226_CR21","first-page":"154","volume":"10","author":"V Deschoolmeester","year":"2008","unstructured":"Deschoolmeester V, Baay M, Wuyts W et al (2008) Detection of microsatellite instability in colorectal cancer using an alternative multiplex assay of quasi-monomorphic mononucleotide markers. J MolDiagn 10:154\u2013159","journal-title":"J MolDiagn"},{"key":"226_CR22","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1111\/j.1349-7006.2008.00737.x","volume":"99","author":"H-L Yan","year":"2008","unstructured":"Yan H-L, Hao L-Q, Jin H-Y et al (2008) Clinical features and mismatch repair genes analyses of Chinese suspected hereditary non-polyposis colorectal cancer: a cost-effective screening strategy proposal. Cancer Sci 99:770\u2013780","journal-title":"Cancer Sci"},{"key":"226_CR23","doi-asserted-by":"crossref","first-page":"2825","DOI":"10.1111\/j.1572-0241.2008.02084.x","volume":"103","author":"C Julie","year":"2008","unstructured":"Julie C, Tresallet C, Brouquet A et al (2008) Identification in daily practice of patients with Lynch syndrome (hereditary nonpolyposis colorectal cancer): revised Bethesda guidelines-based approach versus molecular screening. Am J Gastroenterol 103:2825\u20132835","journal-title":"Am J Gastroenterol"},{"key":"226_CR24","doi-asserted-by":"crossref","unstructured":"Balma\u00c3\u00b1a J, Balaguer F, Castellv\u00c3\u00adBel S et al (2008) Comparison of predictive models, clinical criteria and molecular tumour screening for the identification of patients with Lynch syndrome in a population-based cohort of colorectal cancer patients. J Med Genet 45:557\u2013563","DOI":"10.1136\/jmg.2008.059311"},{"key":"226_CR25","doi-asserted-by":"crossref","first-page":"5783","DOI":"10.1200\/JCO.2008.17.5950","volume":"26","author":"H Hampel","year":"2008","unstructured":"Hampel H, Frankel WL, Martin E et al (2008) Feasibility of screening for Lynch syndrome among patients with colorectal cancer. J ClinOncol 26:5783\u20135788","journal-title":"J ClinOncol"},{"key":"226_CR26","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1093\/jnci\/djn499","volume":"101","author":"RC Green","year":"2009","unstructured":"Green RC, Parfrey PS, Woods MO et al (2009) Prediction of Lynch syndrome in consecutive patients with colorectal cancer. J Natl Cancer Inst 101:331\u2013340","journal-title":"J Natl Cancer Inst"},{"key":"226_CR27","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s00384-009-0784-1","volume":"25","author":"M Molaei","year":"2010","unstructured":"Molaei M, Mansoori BK, Ghiasi S et al (2010) Colorectal cancer in Iran: immunohistochemical profiles of four mismatch repair proteins. Int J Colorectal Dis 25:63\u201369","journal-title":"Int J Colorectal Dis"},{"key":"226_CR28","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s10689-009-9258-4","volume":"8","author":"G Berginc","year":"2009","unstructured":"Berginc G, Bracko M, Ravnik-Glavac M et al (2009) Screening for germline mutations of MLH1, MSH2, MSH6 and PMS2 genes in Slovenian colorectal cancer patients: implications for a population specific detection strategy of Lynch syndrome. Fam Cancer 8:421\u2013429","journal-title":"Fam Cancer"},{"key":"226_CR29","first-page":"375","volume":"37","author":"SMO Leite","year":"2010","unstructured":"Leite SMO, Gomes KB, Pardini VC et al (2010) Assessment of microsatellite instability in colorectal cancer patients from Brazil. MolBiol Rep 37:375\u2013380","journal-title":"MolBiol Rep"},{"key":"226_CR30","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1136\/gut.2010.208462","volume":"59","author":"MO Woods","year":"2010","unstructured":"Woods MO, Younghusband HB, Parfrey PS et al (2010) The genetic basis of colorectal cancer in a population-based incident cohort with a high rate of familial disease. Gut 59:1369\u20131377","journal-title":"Gut"},{"key":"226_CR31","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1016\/j.ejca.2010.03.016","volume":"46","author":"LH Jensen","year":"2010","unstructured":"Jensen LH, Dysager L, Lindebjerg J et al (2010) Molecular biology from bench-to-bedside - which colorectal cancer patients should be referred for genetic counselling and risk assessment. Eur J Cancer 46:1823\u20131828","journal-title":"Eur J Cancer"},{"key":"226_CR32","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1038\/sj.bjc.6605509","volume":"102","author":"G Trano","year":"2010","unstructured":"Trano G, Sjursen W, Wasmuth HH et al (2010) Performance of clinical guidelines compared with molecular tumour screening methods in identifying possible Lynch syndrome among colorectal cancer patients: a Norwegian population-based study. Br J Cancer 102:482\u2013488","journal-title":"Br J Cancer"},{"key":"226_CR33","doi-asserted-by":"crossref","first-page":"707","DOI":"10.3892\/ijo_00000720","volume":"37","author":"P Minoo","year":"2010","unstructured":"Minoo P, Zlobec I, Peterson M et al (2010) Characterization of rectal, proximal and distal colon cancers based on clinicopathological, molecular and protein profiles. Int J Oncol 37:707\u2013718","journal-title":"Int J Oncol"},{"key":"226_CR34","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.surg.2009.10.069","volume":"147","author":"S-C Chang","year":"2010","unstructured":"Chang S-C, Lin P-C, Yang S-H et al (2010) Taiwan hospital-based detection of Lynch syndrome distinguishes 2 types of microsatellite instabilities in colorectal cancers. Surgery 147:720\u2013728","journal-title":"Surgery"},{"key":"226_CR35","doi-asserted-by":"crossref","first-page":"766","DOI":"10.3748\/wjg.v17.i6.766","volume":"17","author":"P Koehler-Santos","year":"2011","unstructured":"Koehler-Santos P, Izetti P, Abud J et al (2011) Identification of patients at-risk for Lynch syndrome in a hospital-based colorectal surgery clinic. World J Gastroenterol 17:766\u2013773","journal-title":"World J Gastroenterol"},{"key":"226_CR36","first-page":"186","volume":"134","author":"G Kaur","year":"2011","unstructured":"Kaur G, Masoud A, Raihan N et al (2011) Mismatch repair genes expression defects & association with clinicopathological characteristics in colorectal carcinoma. Indian J Med Res 134:186\u2013192","journal-title":"Indian J Med Res"},{"key":"226_CR37","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1097\/PAT.0b013e3283437613","volume":"43","author":"CM Egoavil","year":"2011","unstructured":"Egoavil CM, Montenegro P, Soto JL et al (2011) Clinically important molecular features of Peruvian colorectal tumours: high prevalence of DNA mismatch repair deficiency and low incidence of KRAS mutations. Pathology 43:228\u2013233","journal-title":"Pathology"},{"key":"226_CR38","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.3109\/00365521.2011.610003","volume":"46","author":"J Morrison","year":"2011","unstructured":"Morrison J, Bronner M, Leach BH et al (2011) Lynch syndrome screening in newly diagnosed colorectal cancer in general pathology practice: from the revised Bethesda guidelines to a universal approach. Scand J Gastroenterol 46:1340\u20131348","journal-title":"Scand J Gastroenterol"},{"key":"226_CR39","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1038\/modpathol.2011.55","volume":"24","author":"A Mojtahed","year":"2011","unstructured":"Mojtahed A, Schrijver I, Ford JM et al (2011) A two-antibody mismatch repair protein immunohistochemistry screening approach for colorectal carcinomas, skin sebaceous tumors, and gynecologic tract carcinomas. Mod Pathol 24:1004\u20131014","journal-title":"Mod Pathol"},{"key":"226_CR40","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1001\/jama.2012.13088","volume":"308","author":"L Moreira","year":"2012","unstructured":"Moreira L, Balaguer F, Lindor N et al (2012) Identification of Lynch syndrome among patients with colorectal cancer. JAMA 308:1555\u20131565","journal-title":"JAMA"},{"key":"226_CR41","first-page":"857","volume":"33","author":"E Urso","year":"2012","unstructured":"Urso E, Agostini M, Pucciarelli S et al (2012) Clinical and molecular detection of inherited colorectal cancers in northeast Italy: a first prospective study of incidence of Lynch syndrome and MUTYH-related colorectal cancer in Italy. TumourBiol 33:857\u2013864","journal-title":"TumourBiol"},{"key":"226_CR42","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1093\/annonc\/mds614","volume":"24","author":"MA Merok","year":"2013","unstructured":"Merok MA, Ahlquist T, Royrvik EC et al (2013) Microsatellite instability has a positive prognostic impact on stage II colorectal cancer after complete resection: results from a large, consecutive Norwegian series. Ann Oncol 24:1274\u20131282","journal-title":"Ann Oncol"},{"key":"226_CR43","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1136\/gutjnl-2011-300041","volume":"61","author":"L Perez-Carbonell","year":"2012","unstructured":"Perez-Carbonell L, Ruiz-Ponte C, Guarinos C et al (2012) Comparison between universal molecular screening for Lynch syndrome and revised Bethesda guidelines in a large population-based cohort of patients with colorectal cancer. Gut 61:865\u2013872","journal-title":"Gut"},{"key":"226_CR44","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1111\/j.1365-2559.2012.04321.x","volume":"61","author":"W Fadhil","year":"2012","unstructured":"Fadhil W, Ibrahem S, Seth R et al (2012) The utility of diagnostic biopsy specimens for predictive molecular testing in colorectal cancer. Histopathology 61:1117\u20131124","journal-title":"Histopathology"},{"key":"226_CR45","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.canep.2013.07.007","volume":"37","author":"L Raskin","year":"2013","unstructured":"Raskin L, Dakubo JCB, Palaski N et al (2013) Distinct molecular features of colorectal cancer in Ghana. Cancer Epidemiol 37:556\u2013561","journal-title":"Cancer Epidemiol"},{"key":"226_CR46","first-page":"397","volume":"4","author":"EAH Kheirelseid","year":"2013","unstructured":"Kheirelseid EAH, Miller N, Chang KH et al (2013) Mismatch repair protein expression in colorectal cancer. Journal of Gastrointestinal Oncology 4:397\u2013408","journal-title":"Journal of Gastrointestinal Oncology"},{"key":"226_CR47","doi-asserted-by":"crossref","first-page":"2909","DOI":"10.3892\/or.2013.2781","volume":"30","author":"H Terui","year":"2013","unstructured":"Terui H, Tachikawa T, Kakuta M et al (2013) Molecular and clinical characteristics of MSH6 germline variants detected in colorectal cancer patients. Oncol Rep 30:2909\u20132916","journal-title":"Oncol Rep"},{"key":"226_CR48","first-page":"16","volume":"51","author":"F Vergouwe","year":"2013","unstructured":"Vergouwe F, Boutall A, Stupart D et al (2013) Mismatch repair deficiency in colorectal cancer patients in a low-incidence area. S Afr J Surg 51:16\u201321","journal-title":"S Afr J Surg"},{"key":"226_CR49","doi-asserted-by":"crossref","first-page":"5286","DOI":"10.3748\/wjg.v19.i32.5286","volume":"19","author":"S Aissi","year":"2013","unstructured":"Aissi S, Buisine MP, Zerimech F et al (2013) Somatic molecular changes and histo-pathological features of colorectal cancer in Tunisia. World J Gastroenterol 19:5286\u20135294","journal-title":"World J Gastroenterol"},{"key":"226_CR50","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.3892\/ol.2013.1573","volume":"6","author":"N Kamat","year":"2013","unstructured":"Kamat N, Khidhir MA, Alashari MM et al (2013) Microsatellite instability and loss of heterozygosity detected in middle-aged patients with sporadic colon cancer: A retrospective study. Oncology Letters 6:1413\u20131420","journal-title":"Oncology Letters"},{"key":"226_CR51","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1200\/JCO.2012.45.1674","volume":"31","author":"B Heald","year":"2013","unstructured":"Heald B, Plesec T, Liu X et al (2013) Implementation of universal microsatellite instability and immunohistochemistry screening for diagnosing lynch syndrome in a large academic medical center. J ClinOncol 31:1336\u20131340","journal-title":"J ClinOncol"},{"key":"226_CR52","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1016\/j.humpath.2013.06.012","volume":"44","author":"DJ Hartman","year":"2013","unstructured":"Hartman DJ, Brand RE, Hu H et al (2013) Lynch syndrome-associated colorectal carcinoma: frequent involvement of the left colon and rectum and late-onset presentation supports a universal screening approach. Hum Pathol 44:2518\u20132528","journal-title":"Hum Pathol"},{"key":"226_CR53","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1038\/gim.2013.45","volume":"15","author":"E Marquez","year":"2013","unstructured":"Marquez E, Geng Z, Pass S et al (2013) Implementation of routine screening for Lynch syndrome in university and safety-net health system settings: successes and challenges. Genetics in Medicine 15:925\u2013932","journal-title":"Genetics in Medicine"},{"key":"226_CR54","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.jgo.2014.08.002","volume":"5","author":"T Aparicio","year":"2014","unstructured":"Aparicio T, Schischmanoff O, Poupardin C et al (2014) High prevalence of deficient mismatch repair phenotype and the V600E BRAF mutation in elderly patients with colorectal cancer. Journal of Geriatric Oncology 5:384\u2013388","journal-title":"Journal of Geriatric Oncology"},{"key":"226_CR55","doi-asserted-by":"crossref","first-page":"E559","DOI":"10.1002\/ijc.29149","volume":"136","author":"C Kraus","year":"2014","unstructured":"Kraus C, Rau TT, Lux P et al (2014) Comprehensive screening for mutations associated with colorectal cancer in unselected cases reveals penetrant and nonpenetrant mutations. Int J Cancer 136:E559","journal-title":"Int J Cancer"},{"key":"226_CR56","doi-asserted-by":"crossref","first-page":"E181","DOI":"10.1002\/mc.21976","volume":"53","author":"R Raman","year":"2014","unstructured":"Raman R, Kotapalli V, Adduri R et al (2014) Evidence for possible non-canonical pathway(s) driven early-onset colorectal cancer in India. MolCarcinog 53:E181\u2013E186","journal-title":"MolCarcinog"},{"key":"226_CR57","first-page":"2835","volume":"41","author":"P Mokarram","year":"2014","unstructured":"Mokarram P, Rismanchi M, AlizadehNaeeni M et al (2014) Microsatellite instability typing in serum and tissue of patients with colorectal cancer: comparing real time PCR with hybridization probe and high-performance liquid chromatography. MolBiol Rep 41:2835\u20132844","journal-title":"MolBiol Rep"},{"key":"226_CR58","first-page":"965","volume":"20","author":"YJ Choi","year":"2014","unstructured":"Choi YJ, Kim MS, An CH et al (2014) Regional bias of intratumoral genetic heterogeneity of nucleotide repeats in colon cancers with microsatellite instability. PatholOncol Res 20:965\u2013971","journal-title":"PatholOncol Res"},{"key":"226_CR59","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/j.humpath.2014.02.012","volume":"45","author":"E Musul\u00e9n","year":"2014","unstructured":"Musul\u00e9n E, Sanz C, Mu\u00f1oz-M\u00e1rmol AM et al (2014) Mismatch repair protein immunohistochemistry: a useful population screening strategy for Lynch syndrome. Hum Pathol 45:1388\u20131396","journal-title":"Hum Pathol"},{"key":"226_CR60","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1159\/000381284","volume":"91","author":"E Waldmann","year":"2015","unstructured":"Waldmann E, Ferlitsch M, Binder N et al (2015) Tumor and patient characteristics of individuals with mismatch repair deficient colorectal cancer. Digestion 91:286\u2013293","journal-title":"Digestion"},{"key":"226_CR61","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1002\/cncr.29288","volume":"121","author":"AK Siraj","year":"2015","unstructured":"Siraj AK, Prabhakaran S, Bavi P et al (2015) Prevalence of Lynch syndrome in a Middle Eastern population with colorectal cancer. Cancer 121:1762\u20131771","journal-title":"Cancer"},{"key":"226_CR62","doi-asserted-by":"crossref","first-page":"926","DOI":"10.3748\/wjg.v21.i3.926","volume":"21","author":"K Korphaisarn","year":"2015","unstructured":"Korphaisarn K, Pongpaibul A, Limwongse C et al (2015) Deficient DNA mismatch repair is associated with favorable prognosis in Thai patients with sporadic colorectal cancer. World J Gastroenterol 21:926\u2013934","journal-title":"World J Gastroenterol"},{"key":"226_CR63","first-page":"1036","volume":"68","author":"R Colling","year":"2015","unstructured":"Colling R, Church DN, Carmichael J et al (2015) Screening for Lynch syndrome and referral to clinical genetics by selective mismatch repair protein immunohistochemistry testing: an audit and cost analysis. J ClinPathol 68:1036\u20131039","journal-title":"J ClinPathol"},{"key":"226_CR64","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/s11605-014-2687-x","volume":"19","author":"AL Hill","year":"2015","unstructured":"Hill AL, Sumra KK, Russell MM et al (2015) A single institution experience in compliance with universal screening for Lynch syndrome in colorectal cancer. J GastrointestSurg 19:543\u2013550","journal-title":"J GastrointestSurg"},{"key":"226_CR65","doi-asserted-by":"crossref","first-page":"2463","DOI":"10.1007\/s10620-014-3234-z","volume":"60","author":"TD Kidambi","year":"2015","unstructured":"Kidambi TD, Blanco A, Myers M et al (2015) Selective versus universal screening for Lynch syndrome: a six-year clinical experience. Dig Dis Sci 60:2463\u20132469","journal-title":"Dig Dis Sci"},{"key":"226_CR66","doi-asserted-by":"crossref","first-page":"220","DOI":"10.5009\/gnl14310","volume":"10","author":"YB Kim","year":"2016","unstructured":"Kim YB, Lee S-Y, Kim JH et al (2016) Microsatellite instability of gastric and colorectal cancers as a predictor of synchronous gastric or colorectal neoplasms. Gut Liver 10:220\u2013227","journal-title":"Gut Liver"},{"key":"226_CR67","first-page":"w14315","volume":"146","author":"V Zumstein","year":"2016","unstructured":"Zumstein V, Vinzens F, Zettl A et al (2016) Systematic immunohistochemical screening for Lynch syndrome in colorectal cancer: a single centre experience of 486 patients. Swiss Med Week 146:w14315","journal-title":"Swiss Med Week"},{"key":"226_CR68","first-page":"1163","volume":"14","author":"S Berera","year":"2016","unstructured":"Berera S, Koru-Sengul T, Miao F et al (2016) Colorectal tumors from different racial and ethnic minorities have similar rates of mismatch repair deficiency. ClinGastroenterolHepatol 14:1163\u20131171","journal-title":"ClinGastroenterolHepatol"},{"key":"226_CR69","doi-asserted-by":"crossref","first-page":"2887","DOI":"10.1007\/s10620-016-4218-y","volume":"61","author":"MZ Erten","year":"2016","unstructured":"Erten MZ, Fernandez LP, Ng HK et al (2016) Universal versus targeted Sscreening for Lynch syndrome: comparing ascertainment and costs based on clinical experience. Dig Dis Sci 61:2887\u20132895","journal-title":"Dig Dis Sci"},{"key":"226_CR70","first-page":"361","volume":"10","author":"B Brennan","year":"2017","unstructured":"Brennan B, Hemmings CT, Clark I et al (2017) Universal molecular screening does not effectively detect Lynch syndrome in clinical practice. TherapeutAdvGastroenterol 10:361\u2013371","journal-title":"TherapeutAdvGastroenterol"},{"key":"226_CR71","first-page":"427","volume":"32","author":"DD Buchanan","year":"2017","unstructured":"Buchanan DD, Clendenning M, Rosty C et al (2017) Tumor testing to identify lynch syndrome in two Australian colorectal cancer cohorts. J GastroenterolHepatol 32:427\u2013438","journal-title":"J GastroenterolHepatol"},{"key":"226_CR72","doi-asserted-by":"crossref","first-page":"14755","DOI":"10.1038\/ncomms14755","volume":"8","author":"S Haraldsdottir","year":"2017","unstructured":"Haraldsdottir S, Rafnar T, Frankel WL et al (2017) Comprehensive population-wide analysis of Lynch syndrome in Iceland reveals founder mutations in MSH6 and PMS2. Nat Commun 8:14755","journal-title":"Nat Commun"},{"key":"226_CR73","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1007\/s12029-017-9954-5","volume":"49","author":"JS Gandhi","year":"2017","unstructured":"Gandhi JS, Goswami M, Sharma A et al (2017) Clinical impact of mismatch repair protein testing on outcome of early staged colorectal carcinomas. J Gastrointest Cancer 49:406","journal-title":"J Gastrointest Cancer"},{"key":"226_CR74","first-page":"332","volume":"20","author":"L Goshayeshi","year":"2017","unstructured":"Goshayeshi L, Khooiee A, Ghaffarzadegan K et al (2017) Screening for Lynch syndrome in cases with colorectal carcinoma from Mashhad. Arch Iran Med 20:332\u2013337","journal-title":"Arch Iran Med"},{"key":"226_CR75","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1002\/cam4.1025","volume":"6","author":"GM O'Kane","year":"2017","unstructured":"O\u2019Kane GM, Ryan \u00c3, McVeigh TP et al (2017) Screening for mismatch repair deficiency in colorectal cancer: data from three academic medical centers. Cancer Med 6:1465\u20131472","journal-title":"Cancer Med"},{"key":"226_CR76","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s10689-017-0009-7","volume":"17","author":"N Abu Freha","year":"2017","unstructured":"Abu Freha N, LeiboviciWeissman Y, Fich A et al (2017) Constitutional mismatch repair deficiency and Lynch syndrome among consecutive Arab Bedouins with colorectal cancer in Israel. Fam Cancer 17:79","journal-title":"Fam Cancer"},{"key":"226_CR77","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1002\/cam4.1088","volume":"6","author":"K Fujiyoshi","year":"2017","unstructured":"Fujiyoshi K, Yamaguchi T, Kakuta M et al (2017) Predictive model for high-frequency microsatellite instability in colorectal cancer patients over 50 years of age. Cancer Med 6:1255\u20131263","journal-title":"Cancer Med"},{"key":"226_CR78","first-page":"191","volume":"47","author":"N Chika","year":"2017","unstructured":"Chika N, Eguchi H, Kumamoto K et al (2017) Prevalence of Lynch syndrome and Lynch-like syndrome among patients with colorectal cancer in a Japanese hospital-based population. Jpn J ClinOncol 47:191","journal-title":"Jpn J ClinOncol"},{"key":"226_CR79","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.21873\/anticanres.11612","volume":"37","author":"DO Irabor","year":"2017","unstructured":"Irabor DO, Oluwasola OA, Ogunbiyi OJ et al (2017) Microsatellite instability is common in colorectal cancer in native Nigerians. Anticancer Res 37:2649\u20132654","journal-title":"Anticancer Res"},{"key":"226_CR80","first-page":"116","volume":"15","author":"AA Hashmi","year":"2017","unstructured":"Hashmi AA, Ali R, Hussain ZF et al (2017) Mismatch repair deficiency screening in colorectal carcinoma by a four-antibody immunohistochemical panel in Pakistani population and its correlation with histopathological parameters. World J SurgOncol 15:116","journal-title":"World J SurgOncol"},{"key":"226_CR81","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1200\/JCO.2016.71.0012","volume":"35","author":"MB Yurgelun","year":"2017","unstructured":"Yurgelun MB, Kulke MH, Fuchs CS et al (2017) Cancer susceptibility gene mutations in individuals with colorectal cancer. J ClinOncol 35:1086\u20131095","journal-title":"J ClinOncol"},{"key":"226_CR82","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s10689-017-9972-2","volume":"16","author":"JE Hunter","year":"2017","unstructured":"Hunter JE, Arnold KA, Cook JE et al (2017) Universal screening for Lynch syndrome among patients with colorectal cancer: patient perspectives on screening and sharing results with at-risk relatives. Fam Cancer 16:377\u2013387","journal-title":"Fam Cancer"},{"key":"226_CR83","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1038\/modpathol.2016.211","volume":"30","author":"T Adar","year":"2017","unstructured":"Adar T, Rodgers LH, Shannon KM et al (2017) A tailored approach to BRAF and MLH1 methylation testing in a universal screening program for Lynch syndrome. Mod Pathol 30:440\u2013447","journal-title":"Mod Pathol"},{"key":"226_CR84","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1200\/JCO.2005.04.1574","volume":"24","author":"D Black","year":"2006","unstructured":"Black D, Soslow RA, Levine DA et al (2006) Clinicopathologic significance of defective DNA mismatch repair in endometrial carcinoma. J ClinOncol 24:1745\u20131753","journal-title":"J ClinOncol"},{"key":"226_CR85","doi-asserted-by":"crossref","first-page":"7810","DOI":"10.1158\/0008-5472.CAN-06-1114","volume":"66","author":"H Hampel","year":"2006","unstructured":"Hampel H, Frankel W, Panescu J et al (2006) Screening for Lynch syndrome (hereditary nonpolyposis colorectal cancer) among endometrial cancer patients. Can Res 66:7810\u20137817","journal-title":"Can Res"},{"key":"226_CR86","first-page":"25","volume":"77","author":"LA Devlin","year":"2008","unstructured":"Devlin LA, Graham CA, Price JH et al (2008) Germline MSH6 mutations are more prevalent in endometrial cancer patient cohorts than Hereditary Non Polyposis Colorectal Cancer cohorts. Ulster Med J 77:25\u201330","journal-title":"Ulster Med J"},{"key":"226_CR87","first-page":"88","volume":"27","author":"YD Choi","year":"2008","unstructured":"Choi YD, Choi J, Kim JH et al (2008) Microsatellite instability at a tetranucleotide repeat in type I endometrial carcinoma. J ExpClin Cancer Res 27:88","journal-title":"J ExpClin Cancer Res"},{"key":"226_CR88","first-page":"486","volume":"114","author":"FJ Backes","year":"2009","unstructured":"Backes FJ, Leon ME, Ivanov I et al (2009) Prospective evaluation of DNA mismatch repair protein expression in primary endometrial cancer. GynecolOncol 114:486\u2013490","journal-title":"GynecolOncol"},{"key":"226_CR89","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1038\/modpathol.2013.67","volume":"26","author":"B Djordjevic","year":"2013","unstructured":"Djordjevic B, Barkoh BA, Luthra R et al (2013) Relationship between PTEN, DNA mismatch repair, and tumor histotype in endometrial carcinoma: retained positive expression of PTEN preferentially identifies sporadic non-endometrioid carcinomas. Mod Pathol 26:1401\u20131412","journal-title":"Mod Pathol"},{"key":"226_CR90","doi-asserted-by":"crossref","first-page":"e79737","DOI":"10.1371\/journal.pone.0079737","volume":"8","author":"C Egoavil","year":"2013","unstructured":"Egoavil C, Alenda C, Castillejo A et al (2013) Prevalence of Lynch syndrome among patients with newly diagnosed endometrial cancers. PLoS ONE 8:e79737","journal-title":"PLoS ONE"},{"key":"226_CR91","first-page":"319","volume":"134","author":"BAL Batte","year":"2014","unstructured":"Batte BAL, Bruegl AS, Daniels MS et al (2014) Consequences of universal MSI\/IHC in screening ENDOMETRIAL cancer patients for Lynch syndrome. GynecolOncol 134:319\u2013325","journal-title":"GynecolOncol"},{"key":"226_CR92","first-page":"686","volume":"7","author":"AS Bruegl","year":"2014","unstructured":"Bruegl AS, Djordjevic B, Batte B et al (2014) Evaluation of clinical criteria for the identification of Lynch syndrome among unselected patients with endometrial cancer. CancerPrev Res 7:686\u2013697","journal-title":"CancerPrev Res"},{"key":"226_CR93","doi-asserted-by":"crossref","first-page":"3932","DOI":"10.1002\/cncr.28933","volume":"120","author":"SE Ferguson","year":"2014","unstructured":"Ferguson SE, Aronson M, Pollett A et al (2014) Performance characteristics of screening strategies for Lynch syndrome in unselected women with newly diagnosed endometrial cancer who have undergone universal germline mutation testing. Cancer 120:3932\u20133939","journal-title":"Cancer"},{"key":"226_CR94","first-page":"7","volume":"137","author":"AI Frolova","year":"2015","unstructured":"Frolova AI, Babb SA, Zantow E et al (2015) Impact of an immunohistochemistry-based universal screening protocol for Lynch syndrome in endometrial cancer on genetic counseling and testing. GynecolOncol 137:7\u201313","journal-title":"GynecolOncol"},{"key":"226_CR95","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1097\/PAS.0000000000000321","volume":"38","author":"AM Mills","year":"2014","unstructured":"Mills AM, Liou S, Ford JM et al (2014) Lynch syndrome screening should be considered for all patients with newly diagnosed endometrial cancer. Am J SurgPathol 38:1501\u20131509","journal-title":"Am J SurgPathol"},{"key":"226_CR96","first-page":"306","volume":"137","author":"MK McConechy","year":"2015","unstructured":"McConechy MK, Talhouk A, Li-Chang HH et al (2015) Detection of DNA mismatch repair (MMR) deficiencies by immunohistochemistry can effectively diagnose the microsatellite instability (MSI) phenotype in endometrial carcinomas. GynecolOncol 137:306\u2013310","journal-title":"GynecolOncol"},{"key":"226_CR97","first-page":"453","volume":"143","author":"A Goverde","year":"2016","unstructured":"Goverde A, Spaander MC, van Doorn HC et al (2016) Cost-effectiveness of routine screening for Lynch syndrome in endometrial cancer patients up to 70\u00a0years of age. GynecolOncol 143:453\u2013459","journal-title":"GynecolOncol"},{"key":"226_CR98","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1097\/PAS.0000000000000544","volume":"40","author":"AM Mills","year":"2016","unstructured":"Mills AM, Sloan EA, Thomas M et al (2016) Clinicopathologic comparison of Lynch syndrome-associated and \u201cLynch-like\u201d endometrial carcinomas identified on universal screening using mismatch repair protein immunohistochemistry. Am J SurgPathol 40:155\u2013165","journal-title":"Am J SurgPathol"},{"key":"226_CR99","first-page":"277A","volume":"97","author":"A Bruegl","year":"2017","unstructured":"Bruegl A, Daniels M, Broaddus RR (2017) Does universal tissue testing provide universal answers? Clinical challenges associated with tumor screening for lynch syndrome associated endometrial cancer. Lab Invest 97:277A","journal-title":"Lab Invest"},{"key":"226_CR100","first-page":"136","volume":"145","author":"CM Cosgrove","year":"2017","unstructured":"Cosgrove CM, Backes FJ, Hampel H et al (2017) A single institution pilot study for universal Lynch syndrome screening: a key step towards statewide screening and care. GynecolOncol 145:136","journal-title":"GynecolOncol"},{"key":"226_CR101","first-page":"44","volume":"145","author":"AK Crim","year":"2017","unstructured":"Crim AK, Perkins VB, Husain S et al (2017) Feasibility of two-antibody vs four-antibody mismatch repair protein immunohistochemistry as initial screening for Lynch syndrome in patients with endometrial adenocarcinoma. GynecolOncol 145:44","journal-title":"GynecolOncol"},{"key":"226_CR102","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.pathol.2017.05.004","volume":"49","author":"F Najdawi","year":"2017","unstructured":"Najdawi F, Crook A, Maidens J et al (2017) Lessons learnt from implementation of a Lynch syndrome screening program for patients with gynaecological malignancy. Pathology 49:457","journal-title":"Pathology"},{"key":"226_CR103","first-page":"115","volume":"36","author":"JC Watkins","year":"2017","unstructured":"Watkins JC, Yang EJ, Muto MG et al (2017) Universal screening for mismatch-repair deficiency in endometrial cancers to identify patients with Lynch syndrome and Lynch-like syndrome. Int J GynecolPathol 36:115\u2013127","journal-title":"Int J GynecolPathol"},{"key":"226_CR104","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1097\/PAS.0b013e31823bc434","volume":"36","author":"A Aysal","year":"2012","unstructured":"Aysal A, Karnezis A, Medhi I et al (2012) Ovarian endometrioid adenocarcinoma: incidence and clinical significance of the morphologic and immunohistochemical markers of mismatch repair protein defects and tumor microsatellite instability. Am J SurgPathol 36:163\u2013172","journal-title":"Am J SurgPathol"},{"key":"226_CR105","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1038\/bjc.2012.452","volume":"107","author":"T Pal","year":"2012","unstructured":"Pal T, Akbari MR, Sun P et al (2012) Frequency of mutations in mismatch repair genes in a population-based study of women with ovarian cancer. Br J Cancer 107:1783\u20131790","journal-title":"Br J Cancer"},{"key":"226_CR106","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1097\/PAS.0000000000000298","volume":"38","author":"MH Chui","year":"2014","unstructured":"Chui MH, Ryan P, Radigan J et al (2014) The histomorphology of Lynch syndrome-associated ovarian carcinomas: toward a subtype-specific screening strategy. Am J SurgPathol 38:1173\u20131181","journal-title":"Am J SurgPathol"},{"key":"226_CR107","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1089\/gtmb.2013.0393","volume":"18","author":"J-H Lee","year":"2014","unstructured":"Lee J-H, Cragun D, Thompson Z et al (2014) Association between IHC and MSI testing to identify mismatch repair-deficient patients with ovarian cancer. Genet Test MolBiomark 18:229\u2013235","journal-title":"Genet Test MolBiomark"},{"key":"226_CR108","first-page":"81","volume":"135","author":"KR Vierkoetter","year":"2014","unstructured":"Vierkoetter KR, Ayabe AR, VanDrunen M et al (2014) Lynch Syndrome in patients with clear cell and endometrioid cancers of the ovary. GynecolOncol 135:81\u201384","journal-title":"GynecolOncol"},{"key":"226_CR109","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1111\/his.12934","volume":"69","author":"PF Rambau","year":"2016","unstructured":"Rambau PF, Duggan MA, Ghatage P et al (2016) Significant frequency of MSH2\/MSH6 abnormality in ovarian endometrioid carcinoma supports histotype-specific Lynch syndrome screening in ovarian carcinomas. Histopathology 69:288\u2013297","journal-title":"Histopathology"},{"key":"226_CR110","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1038\/sj.onc.1209229","volume":"25","author":"P Mongiat-Artus","year":"2006","unstructured":"Mongiat-Artus P, Miquel C, Van der Aa M et al (2006) Microsatellite instability and mutation analysis of candidate genes in urothelial cell carcinomas of upper urinary tract. Oncogene 25:2113\u20132118","journal-title":"Oncogene"},{"key":"226_CR111","first-page":"634","volume":"142","author":"J Giedl","year":"2014","unstructured":"Giedl J, Schneckenpointner R, Filbeck T et al (2014) Low frequency of HNPCC-associated microsatellite instability and aberrant MMR protein expression in early-onset bladder cancer. Am J ClinPathol 142:634\u2013639","journal-title":"Am J ClinPathol"},{"key":"226_CR112","first-page":"322","volume":"27","author":"A Morales-Burgos","year":"2008","unstructured":"Morales-Burgos A, Sanchez JL, Figueroa LD et al (2008) MSH-2 and MLH-1 protein expression in Muir Torre syndrome-related and sporadic sebaceous neoplasms. P R Health Sci J 27:322\u2013327","journal-title":"P R Health Sci J"},{"key":"226_CR113","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5070\/D3666004S1","volume":"14","author":"C Archer-Dubon","year":"2008","unstructured":"Archer-Dubon C, Alvarez-Zavala B, Reyes E et al (2008) Immunohistochemistry screening of sebaceous lesions for Muir-Torre syndrome in a 26-year period in a Mexican population. Dermatol Online J 14:1","journal-title":"Dermatol Online J"},{"key":"226_CR114","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1097\/PAS.0b013e318199edca","volume":"33","author":"L Orta","year":"2009","unstructured":"Orta L, Klimstra DS, Qin J et al (2009) Towards identification of hereditary DNA mismatch repair deficiency: sebaceous neoplasm warrants routine immunohistochemical screening regardless of patient\u2019s age or other clinical characteristics. Am J SurgPathol 33:934\u2013944","journal-title":"Am J SurgPathol"},{"key":"226_CR115","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s10897-012-9552-4","volume":"22","author":"ME Roberts","year":"2013","unstructured":"Roberts ME, Riegert-Johnson DL, Thomas BC et al (2013) Screening for Muir-Torre syndrome using mismatch repair protein immunohistochemistry of sebaceous neoplasms. J Genet Counsel 22:393\u2013405","journal-title":"J Genet Counsel"},{"key":"226_CR116","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1001\/jamadermatol.2014.1217","volume":"150","author":"JN Everett","year":"2014","unstructured":"Everett JN, Raymond VM, Dandapani M et al (2014) Screening for germline mismatch repair mutations following diagnosis of sebaceous neoplasm. JAMA Dermatol 150:1315\u20131321","journal-title":"JAMA Dermatol"},{"key":"226_CR117","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.prp.2014.10.002","volume":"211","author":"M Boennelycke","year":"2015","unstructured":"Boennelycke M, Thomsen BM, Holck S (2015) Sebaceous neoplasms and the immunoprofile of mismatch-repair proteins as a screening target for syndromic cases. Pathol Res Pract 211:78\u201382","journal-title":"Pathol Res Pract"},{"key":"226_CR118","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.humpath.2015.10.005","volume":"49","author":"CJ Jessup","year":"2016","unstructured":"Jessup CJ, Redston M, Tilton E et al (2016) Importance of universal mismatch repair protein immunohistochemistry in patients with sebaceous neoplasia as an initial screening tool for Muir-Torre syndrome. Hum Pathol 49:1\u20139","journal-title":"Hum Pathol"}],"container-title":["Familial Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10689-020-00226-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10689-020-00226-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10689-020-00226-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,28]],"date-time":"2022-01-28T11:29:26Z","timestamp":1643369366000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10689-020-00226-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,11]]},"references-count":118,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["226"],"URL":"https:\/\/doi.org\/10.1007\/s10689-020-00226-w","relation":{},"ISSN":["1389-9600","1573-7292"],"issn-type":[{"value":"1389-9600","type":"print"},{"value":"1573-7292","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,11]]},"assertion":[{"value":"8 October 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 December 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors have no financial, professional, or personal conflicts of interest to report.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}